341 related articles for article (PubMed ID: 28938919)
1. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
[TBL] [Abstract][Full Text] [Related]
2. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
[TBL] [Abstract][Full Text] [Related]
3. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
[TBL] [Abstract][Full Text] [Related]
4. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
6. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.
Rasmussen MH; Jensen NF; Tarpgaard LS; Qvortrup C; Rømer MU; Stenvang J; Hansen TP; Christensen LL; Lindebjerg J; Hansen F; Jensen BV; Hansen TF; Pfeiffer P; Brünner N; Ørntoft TF; Andersen CL
Mol Oncol; 2013 Jun; 7(3):637-46. PubMed ID: 23506979
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells.
Hou N; Guo Z; Zhao G; Jia G; Luo B; Shen X; Bai Y
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):729-741. PubMed ID: 29542167
[TBL] [Abstract][Full Text] [Related]
9. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
10. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
11. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
Gong L; Ren M; Lv Z; Yang Y; Wang Z
DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162
[TBL] [Abstract][Full Text] [Related]
12. miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.
Zhou J; Hu M; Wang F; Song M; Huang Q; Ge B
Int J Med Sci; 2017; 14(10):937-942. PubMed ID: 28924364
[No Abstract] [Full Text] [Related]
13. Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.
Yue B; Cai D; Liu C; Fang C; Yan D
Mol Ther; 2016 Dec; 24(12):2064-2077. PubMed ID: 27633443
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
15. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
Wang D; Li Y; Zhang C; Li X; Yu J
J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
[TBL] [Abstract][Full Text] [Related]
16. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
17. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
19. MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1 in colorectal cancer.
Li HT; Zhang H; Chen Y; Liu XF; Qian J
Cell Physiol Biochem; 2015; 37(3):1044-54. PubMed ID: 26402653
[TBL] [Abstract][Full Text] [Related]
20. miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
Rasmussen MH; Lyskjær I; Jersie-Christensen RR; Tarpgaard LS; Primdal-Bengtson B; Nielsen MM; Pedersen JS; Hansen TP; Hansen F; Olsen JV; Pfeiffer P; Ørntoft TF; Andersen CL
Nat Commun; 2016 Aug; 7():12436. PubMed ID: 27526785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
